|
1
|
Assessment of fracture risk and its
application to screening for postmenopausal osteoporosis. Report of
WHO study group. World Health Organ Tech Rep Ser. 843:1–129.
1994.
|
|
2
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao L, Qin L, Liu L, Wu Y, Han T, Xue L
and Zhang Q: Anthraquinone compounds from Morinda officinalis
inhibit osteoclastic bone resorption in vitro. Chem Biol Interact.
194:97–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Chen B, Pang G, Chen J, Xie J and
Huang H: Anti-osteoporotic activity of puerarin 6′-O-xyloside on
ovariectomized mice and its potential mechanism. Pharm Biol.
54:111–117. 2016. View Article : Google Scholar
|
|
5
|
Zhou ZX and Li LK: Research progress of
traditional Chinese medicine treatment on osteoporosis. Drug
Evaluation. 10:45–47. 2013.
|
|
6
|
Ma XQ, Zheng CJ, Zhang Y, Hu CL, Lin B, Fu
XY, Han LY, Xu LS, Rahman K and Qin LP: Antiosteoporotic flavonoids
from Podocarpium podocarpum. Phytochem Lett. 6:118–122. 2013.
View Article : Google Scholar
|
|
7
|
Du J, Wei YJ, Peng C, Ran X, Zhang H,
Jiang YP, Rahman K and Qin LP: Establishment of a luciferase
assay-based screening system for detecting estrogen receptor
agonists in plant extracts. Bone. 49:572–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng W, Qin R, Li X and Zhou H: Botany,
phytochemistry, pharmacology, and potential application of
Polygonum cuspidatum Sieb.: et Zucc: A review. J Ethnopharmacol.
148:729–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lou T, Jiang W, Xu D, Chen T and Fu Y:
Inhibitory effects of polydatin on lipopolysaccharide-stimulated
RAW 264.7 cells. Inflammation. 38:1213–1220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang HL, Gao JP, Han YL, Xu X, Wu R, Gao Y
and Cui XH: Comparative studies of polydatin and resveratrol on
mutual transformation and antioxidative effect in vivo.
Phytomedicine. 22:553–559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shiyu S, Zhiyu L, Mao Y, Lin B, Lijia W,
Tianbao Z, Jie C and Tingyu L: Polydatin up-regulates Clara cell
secretory protein to suppress phospholipase A2 of lung induced by
LPS in vivo and in vitro. BMC Cell Biol. 12:312011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong M, Ding W, Liao Y, Liu Y, Yan D,
Zhang Y, Wang R, Zheng N, Liu S and Liu J: Polydatin prevents
hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes
and pressure-overload mouse models. Eur J Pharmacol. 746:186–197.
2015. View Article : Google Scholar
|
|
13
|
Wu Y, Xue L, Du W, Huang B, Tang C, Liu C,
Qiu H and Jiang Q: Polydatin restore endothelium-dependent
relaxation in rat aorta rings impaired by high glucose: A novel
insight into the PPARβ-NO signaling pathway. PLoS One.
10:e01262492015. View Article : Google Scholar
|
|
14
|
Kalu DN: The ovariectomized rat model of
postmenopausal bone loss. Bone Miner. 15:175–191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kinghorn AD, Chin YW and Swanson SM:
Discovery of natural product anticancer agents from biodiverse
organisms. Curr Opin Drug Discov Devel. 12:189–196. 2009.PubMed/NCBI
|
|
16
|
Bonifácio BV, dos Santos Ramos MA, da
Silva PB and Bauab TM: Antimicrobial activity of natural products
against Helicobacter pylori: A review. Ann Clin Microbiol
Antimicrob. 13:542014.PubMed/NCBI
|
|
17
|
Cheng YC: Opportunities for traditional
Chinese medicine to address unmet challenges in modern healthcare.
J Tradit Complement Med. 5:2–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Riggs BL and Melton LJ III: Involutional
osteoporosis. New Engl J Med. 314:1676–1686. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue L, Jiao L, Wang Y, Nie Y, Han T, Jiang
Y, Rahman K, Zhang Q and Qin L: Effects and interaction of icariin,
curculigoside, and berberine in er-xian decoction, a traditional
Chinese medicinal formula, on osteoclastic bone resorption. Evid
Based Complement Alternat Med. 2012:4908432012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li F, Yang XL, Yang YN, Guo C, Zhang C,
Yang Z and Li P: Antiosteoporotic activity of echinacoside in
ovariectomized rats. Phytomedicine. 20:549–557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang L, Chen Q, Wang F and Zhang G:
Antiosteoporotic compounds from seeds of Cuscuta chinensis. J
Ethnopharmacol. 135:553–560. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeong BC, Kim TS, Kim HS, Lee SH and Choi
Y: Transmembrane protein 64 reciprocally regulates osteoblast and
adipocyte differentiation by modulating Wnt/β-catenin signaling.
Bone. 78:165–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian J, Xu XJ, Shen L, Yang YP, Zhu R,
Shuai B, Zhu XW, Li CG, Ma C and Lv L: Association of serum Dkk-1
levels with β-catenin in patients with postmenopausal osteoporosis.
J Huazhong Univ Sci Technolog Med Sci. 35:212–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
